Concepts of CNS plasticity in the context of brain damage and repair

Journal of Head Trauma Rehabilitation

Volumn 18, Issue 4, 2003, Pages 317-341

  Stein, Donald G ^a   Hoffman, Stuart W ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Diaschisis; Equipotentiality; Neuroplasticity; Neuroreorganization; Neurotherapies; Recovery of function; Vicariation

Indexed keywords

3ALPHA REDUCTASE; ANTIOXIDANT; EXCITOTOXIN; GESTAGEN; NEUROSTEROID; NEUROTROPHIC FACTOR; PROGESTERONE; SCAVENGER; UNCLASSIFIED DRUG;

BRAIN EDEMA; BRAIN INJURY; CELL METABOLISM; CENTRAL NERVOUS SYSTEM PLASTICITY; CLINICAL TRIAL; DRUG MECHANISM; GENOME; HUMAN; LIPID PEROXIDATION; MOLECULAR MECHANICS; NERVE CELL PLASTICITY; NERVE REGENERATION; NEUROPROTECTION; OUTCOMES RESEARCH; REVIEW; STEM CELL TRANSPLANTATION;

EID: 0041807584     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001199-200307000-00004     Document Type: Review

References (161)

1. Bullock MR, Lyeth BG, Muizelaar JP. Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery 1999;45:207-217.
2. Fawcett James W, Rosser AE, Dunnett SB. Brain Damage, Brain Repair. Oxford: Oxford University Press; 2001.
3. Goldstein G, Beers SR. Rehabilitation. New York: Plenum Press; 1998.
4. Levin HS, Grafman J. Cerebral Reorganization of Function After Brain Damage. New York: Oxford University Press; 2000.
5. Stein DG, Brailowsky S, Will B. Brain Repair. New York: Oxford University Press; 1995.
6. Stuss DT, Winocus G, Robertson IH. Cognitive Neurorehabilitation. Cambridge, UK: Cambridge University Press; 1999.
7. Allen C, Bekoff M, Lauder GV. Nature's Purposes: Analyses of Function and Design in Biology. Cambridge, MA: The MIT Press; 1998.
8. Goldberger. Recovery of movement after CNS lesions in monkeys. In: Stein DG, Rosen JJ, Butters N, eds. Plasticity and Recovery of Function in the Central Nervous System. New York: Academic Press; 1974:265-338.
9. LeVere N, Gray-Silvia S, LeVere TE. Neural system imbalances and the consequence of large brain injuries. In: Finger S, LeVere TE, Almli CR, Stein DG, eds. Brain Injury and Recovery: Theoretical and Controversial Issues. New York: Plenum; 1988:15-27.
10. Kosik KS. Opinion: beyond phrenology, at last. Nat Rev Neurosci. 2003;4:234-239.
11. Anderson VA, Catroppa C, Rosenfeld J, Haritou F, Morse SA. Recovery of memory function following traumatic brain injury in pre-school children. Brain Inj. 2000;14:679-692.
12. Jordan FM, Murdoch BE. Unexpected recovery of functional communication following a prolonged period of mutism post-head injury. Brain Inj. 1990;4:101-108.
13. Finger S, Wolf C. The "Kennard effect" before Kennard. The early history of age and brain lesions. Arch Neurol. 1988;45:1136-1142.
14. Prins ML, Hovda DA. Mapping cerebral glucose metabolism during spatial learning: interactions of development and traumatic brain injury. J Neurotrauma. 2001;18:31-46.
15. Trudeau N, Poulin-Dubois D, Joanette Y. Language development following brain injury in early childhood: a longitudinal case study. Int J Lang Commun Disord. 2000;35:227-249.
16. Kolb B, Gibb R, Gorny G. Cortical plasticity and the development of behavior after early frontal cortical injury. Dev Neuropsychol. 2000;18:423-444.
17. Kolb B, Cioe J. Recovery from early cortical damage in rats, VIII. Earlier may be worse: behavioural dysfunction and abnormal cerebral morphogenesis following perinatal frontal cortical lesions in the rat. Neuropharmacology. 2000;39:756-764.
18. Slavin MD, Laurence S, Stein DG. Another look at vicariation. In: Finger S, LeVere TE, Almli CR, Stein DG, eds. Brain Injury and Recovery: Theoretical and Controversial Issues. New York: Plenum; 1988:165-178.
19. Xerri C, Merzenich MM, Peterson BE, Jenkins W. Plasticity of primary somatosensory cortex paralleling sensorimotor skill recovery from stroke in adult monkeys. J Neurophysiol. 1998;79:2119-2148.
20. Beaulieu CL. Rehabilitation and outcome following pediatric traumatic brain injury. Surg Clin North Am. 2002;82:393-408.
21. Kolb B, Gibb R, Gonzoalez C. Cortical injury and neuroplasticity during development. In: Shaw CA, McEachern JC, eds. Toward a Theory of Neuroplasticity. Philadelphia: Psychology Press; 2001:xvii, 479.
22. LeVere N, Gray-Silva S, LeVere TE. Infant brain injury: the benefit of relocation and the cost of crowding. In: Finger S, LeVere TE, Almli CR, Stein DG, eds. Brain Injury and Recovery: Theoretical and Controversial Issues. New York: Plenum Press; 1988:133-148.
23. LeVere ND. Recovery of function after brain damage: differences in aged rats? Neurobiol Aging. 1983;4:181-185.
24. Nudo RJ, Plautz EJ, Frost SB. Role of adaptive plasticity in recovery of function after damage to motor cortex. Muscle Nerve. 2001;24:1000-1019.
25. Snow PJ, Nudo RJ, Rivers W, Jenkins WM, Merzenich MM. Somatotopically inappropriate projections from thalamocortical neurons to the SI cortex of the cat demonstrated by the use of intracortical microstimulation. Somatosens Res. 1988;5:349-372.
26. York GK, Steinberg DA. Hughlings Jackson's theory of recovery. Neurology. 1995;45:834-838.
27. Finger S, Stein DG. Brain Damage and Recovery: Research and Clinical Perspectives. New York: Academic Press; 1982.
28. Stein DG, Finger S, Hart T. Brain damage and recovery: problems and perspectives. Behav Neural Biol. 1983;37:185-222.
29. Seltz RJ, Freund HJ. Plasticity of the human motor cortex. Adv Neurol. 1997;73:321-333.
30. Lenneberg EH. Biological Foundations of Language. New York: Wiley; 1967.
31. Kennard MA. Cortical reorganization of motor function. Studies on series of monkeys of various ages from infancy to maturity. Arch Neurol Psychiatry. 1942;48:227-240.
32. Goldman PS, Galkin TW. Prenatal removal of frontal association cortex in the fetal rhesus monkey: anatomical and functional consequences in postnatal life. Brain Res. 1978;152:451-485.
33. Vargha-Khadem F, Isaacs E, Muter V. A review of cognitive outcome after unilateral lesions sustained during childhood. J Child Neurol. 1994;9(Suppl 2):67-73.
34. Monakow CV. Die Lokalisation im Grosshirn und der Abbau der Funktion Durch Kortikale Herde. Wiesbaden, Germany: J.F. Bergmann; 1914.
35. Hausen HS, Lachmann EA, Nagler W. Cerebral diaschisis following cerebellar hemorrhage. Arch Phys Med Rehabil. 1997;78:546-549.
36. Imahori Y, Fujii R, Kondo M, Ohmori Y, Nakajima K. Neural features of recovery from CNS injury revealed by PET in human brain. Neuroreport. 1999;10:117-121.
37. Laatsch L, Jobe T, Sychra J, Lin Q, Blend M. Impact of cognitive rehabilitation therapy on neuropsychological impairments as measured by brain perfusion SPECT: a longitudinal study. Brain Inj. 1997;11:851-863.
38. Rosen HJ, Petersen SE, Linenweber MR, et al. Neural correlates of recovery from aphasia after damage to left inferior frontal cortex. Neurology. 2000;55:1883-1894.
39. Feeney DM, Sutton RL. Pharmacotherapy for recovery of function after brain injury. Crit Rev Neurobiol. 1987;3:135-197.
40. Gladstone DJ, Black SE. Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier? Can J Neurol Sci. 2000;27:97-105.
41. Small SL, Hlustik P, Noll DC, Genovese C, Solodkin A. Cerebellar hemispheric activation ipsilateral to the paretic hand correlates with functional recovery after stroke. Brain. 2002;125:1544-1557.
42. Price CJ, Warburton EA, Moore CJ, Frackowiak RS, Friston KJ. Dynamic diaschisis: Anatomically remote and context-sensitive human brain lesions. J Cogn Neurosci. 2001;13:419-429.
43. Stein DG. In pursuit of new strategies for understanding recovery from brain damage: problems and perspectives. In: Boll TJ, Bryant BK, eds. Clinical Neuropsychology and Brain Function: Research, Measurement, and Practice. Washington, DC: American Psychological Association; 1988:9-56.
44. Luria AR. Higher Cortical Functions in Man. New York: Basic Books; 1966.
45. Merrill EG, Wall PD. Plasticity of connection in the adult nervous system. In: Cotman CW, ed. Neuronal Plasticity. New York: Raven Press; 1978:97-111.
46. Pons TP, Garraghty PE, Ommaya AK, Kaas JH, Taub E, Mishkin M. Massive cortical reorganization after sensory deafferentation in adult macaques. Science. 1991;252:1857-1860.
47. Ramachandran VS, Blakeslee S. Phantoms in the Brain: Probing the Mysteries of the Human Mind. New York: William Morrow; 1998.
48. Ramachandran VS, Rogers-Ramachandran D. Phantom limbs and neural plasticity. Arch Neurol. 2000;57:317-320.
49. Rauschecker JP. Compensatory plasticity and sensory substitution in the cerebral cortex. Trends Neurosci, 1995;18:36-43.
50. Rauschecker JP. Mechanisms of compensatory plasticity in the cerebral cortex. In: Freund HJ, Sabel BA, Witte OW, eds. Advances in Neurology. Philadelphia: Lippincott-Raven; 1997:137-146.
51. Jenkins WM, Merzenich MM. Reorganization of neocortical representations after brain injury: a neurophysiological model of the bases of recovery from stroke. Prog Brain Res. 1987;71:249-266.
52. Merzenich M, Wright B, Jenkins W, et al. Cortical plasticity underlying perceptual, motor, and cognitive skill development: implications for neurorehabilitation. Cold Spring Harb Symp Quant Biol. 1996;61:1-8.
53. Wolf SL, Lecraw DE, Barton LA, Jann BB. Forced use of hemiplegic upper extremities to reverse the effect of learned nonuse among chronic stroke and head-injured patients. Exp Neurol. 1989;104:125-132.
54. Lashley K. Functional determinants of cerebral localization. Arch Neurol Psychiatry. 1937;38:371-387.
55. Goldstein K. The Organism, a Holistic Approach to Biology Derived from Pathological Data in Man. New York: American Book Company; 1939.
56. Luria AR. Human Brain and Psychological Processes. New York: Harper & Row; 1966.
57. Roberts I, Schierhout G, Alderson P. Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review. J Neurol Neurosurg Psychiatry. 1998;65:729-733.
58. Guerrero JL, Thurman DJ, Sniezek JE. Emergency department visits associated with traumatic brain injury: United States, 1995-1996. Brain Inj. 2000;14:181-186.
59. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. 1999;14:602-615.
60. Adekoya N, Thurman DJ, White DD, Webb KW. Surveillance for traumatic brain injury deaths - United States, 1989-1998. MMWR. 2002;51:1-14.
61. Kovalovsky D, Refojo D, Holsboer F, Arzt E. Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production. J Neuroimmunol. 2000;109:23-29.
62. Scherbel U, Raghupathi R, Nakamura M, et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci USA. 1999;96:8721-8726.
63. Lenzlinger PM, Morganti-Kossmann MC, Laurer HL, McIntosh TK. The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol. 2001;24:169-181.
64. Hill WD, Hess DC, Carroll JE, et al. The NF-kappaB inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia. Brain Res Bull, 2001;55:375-386.
65. Tamatani M, Mitsuda N, Matsuzaki H, et al. A pathway of neuronal apoptosis induced by hypoxia/reoxygenation: roles of nuclear factor-kappaB and Bcl-2. J Neurochem. 2000;75:683-693.
66. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci. 2001;21:5528-5534.
67. Marshall LF, Maas AI, Marshall SB, et al. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J Neurosurg. 1998;89:519-25.
68. Young B, Runge JW, Waxman KS, et al. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial [see comments]. JAMA. 1996;276:538-543.
69. Bath PM, Iddenden R, Bath FJ, Orgogozo JM. Tirilazad for acute ischaemic stroke. Cochrane Database Syst Rev. 2001;CD002087.
70. Bullock R. Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies. Ann N Y Acad Sci. 1995;765:272-278.
71. Merchant RE, Bullock MR, Carmack CA, et al. A double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury. Ann N Y Acad Sci. 1999;890:42-50.
72. Morris GF, Bullock R, Marshall SB, Marmarou A, Maas A, Marshall LF. Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J Neurosurg. 1999;91:737-743.
73. Davis SM, Albers GW, Diener HC, Lees KR, Norris J. Termination of acute stroke studies involving selfotel treatment. ASSIST Steering Committee. Lancet. 1997;349:32.
74. Faden AI. Neuroprotection and traumatic brain injury: the search continues. Arch Neurol. 2001;58: 1553-1555.
75. U.S. Preventive Services Task Force. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. Ann Intern Med. 2002;137:834-839.
76. Baulieu EE. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res. 1997;52:1-32.
77. Roof RL, Hoffman SW, Stein DG. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol. 1997;311:1-11.
78. Subramanian M, Pusphendran CK, Tarachand U, Devasagayam TP. Gestation confers temporary resistance to peroxidation in the maternal rat brain. Neurosci Lett. 1993;155:151-154.
79. Goodman Y, Bruce AJ, Cheng B, Mattson MP. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem. 1996;66:1836-1844.
80. Lockhart EM, Warner DS, Pearlstein RD, Penning DH, Mehrabani S, Boustany RM. Allopregnanolone attenuates N-methyl-D-aspartate-induced excitotoxicity and apoptosis in the human NT2 cell line in culture. Neurosci Lett. 2002;328:33-36.
81. Garcia-Estrada J, Del Rio JA, Luquin S, Soriano E, Garcia-Segura LM. Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Res. 1993;628:271-278.
82. Garcia-Estrada J, Luquin S, Fernandez AM, Garcia-Segura LM. Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int J Dev Neurosci. 1999;17:145-151.
83. Murphy SJ, Littleton-Kearney MT, Hurn PD. Progesterone administration during reperfusion, but not preischemia alone, reduces injury in ovariectomized rats. J Cereb Blood Flow Metab. 2002;22: 1181-1188.
84. Malcolm SG, Cargill RS. Progesterone protects neurons from mitochondrial damage after in vitro injury. J Neurotrauma. 2000;17:967.
85. Chen J, Chopp M, Li Y. Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J Neurol Sci. 1999;171:24-30.
86. Asbury ET, Fritts ME, Horton JE, Isaac WL. Progesterone facilitates the acquisition of avoidance learning and protects against subcortical neuronal death following prefrontal cortex ablation in the rat. Behav Brain Res. 1998;97:99-106.
87. Roof RL, Duvdevani R, Stein DG. Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor Neurol Neurosci. 1992;4:425-427.
88. Roof RL, Duvdevani R, Braswell L, Stein DG. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol. 1994;129:64-69.
89. Wright DW, Bauer ME, Hoffman SW, Stein DG. Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats. J Neurotrauma. 2001;18:901-909.
90. Hall ED. Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J Neurol Sci. 1995;134(Suppl):79-83.
91. Hoffman SW, Moore S, Ellis EF. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke. 1997;28:844-849.
92. Hoffman SW, Roof RL, Stein DG. A reliable and sensitive enzyme immunoassay method for measuring 8-isoprostaglandin F2 alpha: a marker for lipid peroxidation after experimental brain injury. J Neurosci Methods. 1996;68:133-136.
93. Pettus E, Wright DW, Hoffman SW, Stein DG. The neuroprotective effects of progesterone are associated with modified gene expression in rat cortical impact model. J Neurotrauma. 2002;19: 1286.
94. Djebaili MJ, Hoffman SW, Stein DG. The neuroprotective effects of progesterone and allopregnanolone after controlled cortical impact in rats. J Neurotrauma. 2002;19:1287.
95. Baulieu EE. Neurosteroids: a new function in the brain. Biol Cell 1991;71(1-2):3-10.
96. Bell KR, Pepping M. Women and traumatic brain injury. Phys Med Rehabil Clin N Am. 2001;12:169-182.
97. Hulst LK, Fleishaker JC, Peters GR, Harry JD, Wright DM, Ward P. Effect of age and gender on tirilazad pharmacokinetics in humans. Clin Pharmacol Ther. 1994;55:378-384.
98. Schwartz-Bloom RD, McDonough KJ, Chase PJ, Chadwick LE, Inglefield JR, Levin ED. Long-term neuroprotection by benzodiazepine full versus partial agonists after transient cerebral ischemia in the gerbil [corrected]. J Cereb Blood Flow Metab. 1998;18:548-558.
99. Schallert T, Jones TA, Lindner MD. Multilevel transneuronal degeneration after brain damage. Behavioral events and effects of anticonvulsant gamma-aminobutyric acid-related drugs. Stroke. 1990;21(11 Suppl):III143-III146.
100. Jones TA, Schallert T. Subcortical deterioration after cortical damage: effects of diazepam and relation to recovery of function. Behav Brain Res. 1992;51:1-13.
101. Leskiewicz M, Budziszewska B, Jaworska-Feil L, Lason W. Effects of neurosteroids on kainate-induced seizures, neurotoxicity and lethality in mice. Pol J Pharmacol, 1997;49:411-417.
102. Ladurelle N, Eychenne B, Denton D, et al. Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse. Brain Res. 2000;858:371-379.
103. Park KI, Ourednik J, Ourednik V, et al. Global gene and cell replacement strategies via stem cells. Gene Ther. 2002;9:613-624.
104. Bragin A, Wilson CL, Engel J Jr. Chronic epileptogenesis requires development of a network of pathologically interconnected neuron clusters: a hypothesis. Epilepsia. 2000;41(Suppl 6):S144-S152.
105. Krenz NR, Weaver LC. Sprouting of primary afferent fibers after spinal cord transection in the rat. Neuroscience. 1998;85:443-458.
106. Pasterkamp RJ, Verhaagen J. Emerging roles for semaphorins in neural regeneration. Brain Res Brain Res Rev. 2001;35:36-54.
107. Doherty P, Williams G, Williams EJ. CAMs and axonal growth: a critical evaluation of the role of calcium and the MAPK cascade. Mol Cell Neurosci. 2000;16:283-295.
108. Huber AB, Schwab ME. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biol Chem. 2000;381:407-419.
109. Chu CJ, Jones TA. Experience-dependent structural plasticity in cortex heterotopic to focal sensorimotor cortical damage. Exp Neurol. 2000;166:403-414.
110. Miller WL. Use of recombinant DNA technology for the production of polypeptides. Adv Exp Med Biol. 1979;118:153-174.
111. Hefti F. Development of effective therapy for Alzheimer's disease based on neurotrophic factors. Neurobiol Aging. 1994;15(Suppl 2):S193-S194.
112. Cuevas Sanchez P. How neurotrophic factors protect brain against excitotoxicity. Surg Neurol 1996;46:152-153.
113. Figueiredo BC, Piccardo P, Maysinger D, Clarke PB, Cuello AC. Effects of acidic fibroblast growth factor on cholinergic neurons of nucleus basalis magnocellularis and in a spatial memory task following cortical devascularization. Neuroscience. 1993;56:955-963.
114. McDermott KL, Raghupathi R, Fernandez SC, et al. Delayed administration of basic fibroblast growth factor (bFGF) attenuates cognitive dysfunction following parasagittal fluid percussion brain injury in the rat. J Neurotrauma. 1997;14:191-200.
115. Bizon JL, Lauterborn JC, Isackson PJ, Gall CM. Acidic fibroblast growth factor mRNA is expressed by basal forebrain and striatal cholinergic neurons. J Comp Neurol, 1996;366:379-389.
116. Clark WM, Schim JD, Kasner SE, Victor SJ. Trafermin in acute ischemic stroke: results of a phase II/III randomized efficacy study. Neurology, 2000;54(Suppl 3):A88.
117. Fraher JP. The transitional zone and CNS regeneration. J Anat. 1999;194:161-182.
118. Seri B, Garcia-Verdugo JM, McEwen BS, Alvarez-Buylla A. Astrocytes give rise to new neurons in the adult mammalian hippocampus. J Neurosci. 2001;21(18):7153-60.
119. Doering LC, Snyder EY. Cholinergic expression by a neural stem cell line grafted to the adult medial septum/diagonal band complex. J Neurosci Res. 2000;61:597-604.
120. Lu D, Mahmood A, Wang L, Li Y, Lu M, Chopp M. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport. 2001;12:559-563.
121. Ma Y, Feigin A, Dhawan V, et al. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol. 2002;52:628-634.
122. Borlongan CV, Saporta S, Poulos SG, Othberg A, Sanberg PR. Viability and survival of hNT neurons determine degree of functional recovery in grafted ischemic rats. Neuroreport. 1998;9:2837-2842.
123. Saporta S, Makoui AS, Willing AE, Daadi M, Cahill DW, Sanberg PR. Functional recovery after complete contusion injury to the spinal cord and transplantation of human neuroteratocarcinoma neurons in rats. J Neurosurg. 2002;97(1 Suppl):63-68.
124. Feeney DM. From laboratory to clinic: noradrenergic enhancement of physical therapy for stroke or trauma patients. Adv Neurol. 1997;73:383-394.
125. Feeney DM, Weisend MP, Kline AE. Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. J Neural Transplant Plast. 1993;4:199-213.
126. Goldstein LB, Pharmacological approach to functional reorganization: the role of norepinephrine. Rev Neurol. 1999;155:731-736.
127. Kline AE, Massucci JL, Marion DW, Dixon CE. Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J Neurotrauma. 2002;19:415-425.
128. Zhu J, Hamm RJ, Reeves TM, Povlishock JT, Phillips LL. Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. Exp Neurol. 2000;166:136-152.
129. Temple MD, Hamm RJ. Chronic, post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury. Brain Res. 1996;741:246-251.
130. Dixon CE, Ma X, Marion DW. Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. J Neurotrauma. 1997;14:161-169.
131. Kozlowski DA, Schallert T. Relationship between dendritic pruning and behavioral recovery following sensorimotor cortex lesions. Behav Brain Res 1998;97(1-2):89-98.
132. Schallert T, Hernandez TD, Barth TM. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res. 1986;379:104-111.
133. Stibick DL, Feeney DM. Enduring vulnerability to transient reinstatement of hemiplegia by prazosin after traumatic brain injury. J Neurotrauma, 2001;18:303-312.
134. Faugier-Grimaud S, Frenois C, Stein DG. Effects of posterior parietal lesions on visually guided behavior in monkeys. Neuropsychologia. 1978;16:151-168.
135. Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. 1982;217:855-857.
136. Liepert J, Bauder H, Wolfgang HR, Miltner WH, Taub E, Weiller C. Treatment-induced cortical reorganization after stroke in humans. Stroke. 2000;31:1210-1216.
137. Blanton S, Wolf SL. An application of upper-extremity constraint-induced movement therapy in a patient with subacute stroke. Phys Ther. 1999;79:847-853.
138. Friel KM, Heddings AA, Nudo RJ. Effects of postlesion experience on behavioral recovery and neurophysiologic reorganization after cortical injury in primates. Neurorehabil Neural Repair. 2000;14:187-198.
139. Kunkel A, Kopp B, Muller G, et al. Constraint-induced movement therapy for motor recovery in chronic stroke patients. Arch Phys Med Rehabil. 1999;80:624-628.
140. Farrell R, Evans S, Corbett D. Environmental enrichment enhances recovery of function but exacerbates ischemic cell death. Neuroscience. 2001;107:585-592.
141. Humm JL, Kozlowski DA, James DC, Gotts JE, Schallert T. Use-dependent exacerbation of brain damage occurs during an early post-lesion vulnerable period. Brain Res. 1998;783:286-292.
142. Humm JL, Kozlowski DA, Bland ST, James DC, Schallert T. Use-dependent exaggeration of brain injury: is glutamate involved? Exp Neurol. 1999;157:349-358.
143. Majewska MD, Demirgoren S, Spivak CE, London ED. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 1990;526:143-146.
144. Wolf OT, Kirschbaum C. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res Brain Res Rev. 1999;30:264-288.
145. Bergeron R, de Montigny C, Debonnel G. Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate. Naunyn Schmiedebergs Arch Pharmacol. 1995;351:252-260.
146. Bergeron R, de Montigny C, Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 1996;16:1193-1202.
147. Monnet FP, Mahe V, Robel P, Baulieu EE. Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci USA. 1995;92:3774-3778.
148. Rhodes ME, Li PK, Flood JF, Johnson DA. Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: an in vivo microdialysis study. Brain Res. 1996;733:284-286.
149. Schmidt RH, Grady MS. Loss of forebrain cholinergic neurons following fluid-percussion injury: implications for cognitive impairment in closed head injury. J Neurosurg. 1995;83:496-502.
150. DeAngelis MM, Hayes RL, Lyeth BG. Traumatic brain injury causes a decrease in M2 muscarinic cholinergic receptor binding in the rat brain. Brain Res. 1994;653:39-44.
151. Dixon CE, Hamm RJ, Taft WC, Hayes RL. Increased anticholinergic sensitivity following closed skull impact and controlled cortical impact traumatic brain injury in the rat. J Neurotrauma. 1994;11:275-287.
152. Dixon CE, Bao J, Long DA, Hayes RL. Reduced evoked release of acetylcholine in the rodent hippocampus following traumatic brain injury. Pharmacol Biochem Behav. 1996;53:679-686.
153. Dixon CE, Ma X, Marion DW. Reduced evoked release of acetylcholine in the rodent neocortex following traumatic brain injury. Brain Res. 1997;749:127-130.
154. Virmani S, Simkins RM, Stein DG, Hoffman SW. The delayed administration of dehydroepiandrosterone sulfate promotes recovery of function after cortical impact injury. J Neurotrauma. In press.
155. Hoffman SW, Pettus EH, Simkins RM, Stein DG. Delayed treatment with dehydroepiandrosterone sulfate enhances gene expression related to neuroplasticity. J Neurotrauma. In press.
156. Pieper DR, Lobocki CA, Lichten EM, Malaczynski J. Dehydroepiandrosterone and exercise in golden hamsters. Physiol Behav. 1999;67:607-610.
157. Muter V, Taylor S, Vargha-Khadem F. A longitudinal study of early intellectual development in hemiplegic children. Neuropsychologia 1997;35:289-298.
158. Finger S, Beyer T, Koehler PJ. Dr. Otto Soltmann (1876) on development of the motor cortex and recovery after its removal in infancy. Brain Res Bull. 2000;53:133-140.
159. Rosenblum WI, Nelson GH, Bei RA, Brandt RB, Chan W. Vitamin E ameliorates adverse effects of endothelial injury in brain arterioles. Am J Physiol. 1996;271(2 Pt 2):H637-H642.
160. Green EJ, Dietrich WD, van Dijk F, et al. Protective effects of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats. Brain Res. 1992;580:197-204.
161. Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke. 1995;26:2254-2259.